MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients
出版年份 2011 全文链接
标题
MiR-195, miR-196b, miR-181c, miR-21 expression levels and O-6-methylguanine-DNA methyltransferase methylation status are associated with clinical outcome in glioblastoma patients
作者
关键词
-
出版物
CANCER SCIENCE
Volume 102, Issue 12, Pages 2186-2190
出版商
Wiley
发表日期
2011-09-05
DOI
10.1111/j.1349-7006.2011.02092.x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- MicroRNAs and glioblastoma: roles in core signalling pathways and potential clinical implications
- (2011) Jiri Sana et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Immunohistochemical detection of HSP27 and hnRNP K as prognostic and predictive biomarkers for colorectal cancer
- (2011) Feng Wang et al. MEDICAL ONCOLOGY
- A Ten-microRNA Expression Signature Predicts Survival in Glioblastoma
- (2011) Sujaya Srinivasan et al. PLoS One
- microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells
- (2010) Lin Liu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miR-195, miR-455-3p and miR-10a∗ are implicated in acquired temozolomide resistance in glioblastoma multiforme cells
- (2010) Kenta Ujifuku et al. CANCER LETTERS
- MiRNA-196 Is Upregulated in Glioblastoma But Not in Anaplastic Astrocytoma and Has Prognostic Significance
- (2010) Y. Guan et al. CLINICAL CANCER RESEARCH
- MicroRNA-181 family predicts response to concomitant chemoradiotherapy with temozolomide in glioblastoma patients
- (2010) O. Slaby et al. NEOPLASMA
- MicroRNA involvement in glioblastoma pathogenesis
- (2009) Jana Novakova et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical Cancer
- (2009) P. S. H. Soon et al. CLINICAL CANCER RESEARCH
- MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells
- (2009) Teng Xu et al. HEPATOLOGY
- Molecular Predictors of Progression-Free and Overall Survival in Patients With Newly Diagnosed Glioblastoma: A Prospective Translational Study of the German Glioma Network
- (2009) Michael Weller et al. JOURNAL OF CLINICAL ONCOLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G
- (2008) Yang Chen et al. CANCER LETTERS
- MicroRNA-21 Targets a Network of Key Tumor-Suppressive Pathways in Glioblastoma Cells
- (2008) T. Papagiannakopoulos et al. CANCER RESEARCH
- MGMT promoter hypermethylation correlates with a survival benefit from temozolomide in patients with recurrent anaplastic astrocytoma but not glioblastoma
- (2008) J. Sadones et al. EUROPEAN JOURNAL OF CANCER
- Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity
- (2008) Monika E. Hegi et al. JOURNAL OF CLINICAL ONCOLOGY
- MGMTPromoter Methylation Status Can Predict the Incidence and Outcome of Pseudoprogression After Concomitant Radiochemotherapy in Newly Diagnosed Glioblastoma Patients
- (2008) Alba A. Brandes et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started